In clear cell renal cell carcinoma, FTO restores mitochondrial activity and reduces oxidative stress, impairing tumor growth via the FTO-PGC-1α signaling axis (Zhuang et al., 2019). This evidence concerns the gene PPARGC1A and neoplasm.